Literature DB >> 546790

Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.

M Nasseri, F Z Modabber.   

Abstract

The susceptibility of a few strains of mice to a subcutaneous injection of Leishmania tropica major, the causative agent of cutaneous leishmaniasis in humans, was studied. The infection in six strains (CBA, AKR/J, AKR/cu, C57BL/6, A/J, and C3H) remained cutaneous, and the animals recovered within 3 to 4 months. In contast, the infection in BALB/c became generalized and killed 1005 of infected animals. Intraperitoneal injection of infected liver of BALB/c to A/J and syngeneic mice produced a lethal disease in BALB/c but no infection in A/J mice. Lower doses of the parasite produced a lethal infection in BALB/c but no apparent disease in A/J. Hence, the host rather than the parasite is responsible for the outcome of the disease. The peak antibody titer of BALB/c mice was not significantly higher than that of A/J mice. However, BALB/c failed to show any delayed hypersensitivity to leishmania tested by footpad reaction, whereas A/J mice showed a strong response.

Entities:  

Mesh:

Year:  1979        PMID: 546790      PMCID: PMC414661          DOI: 10.1128/iai.26.2.611-614.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.

Authors:  R Behin; J Mauel; D S Rowe
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.

Authors:  P M Preston; R L Carter; E Leuchars; A J Davies; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

3.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

4.  Problems in leishmaniasis related to immunology.

Authors:  P C Garnham; J H Humphrey
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

5.  Letter: Genetic control of natural resistance to Leishmania donovani.

Authors:  D J Bradley
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

6.  Epidemiology of cutaneous leishmaniasis in Iran: B. Khorassan Part V: Report on a focus of zoonotic cutaneous leishmaniasis in Esferayen.

Authors:  E Javadian; A Nadim; G Tahvildare-Bidruni; V Assefi
Journal:  Bull Soc Pathol Exot Filiales       Date:  1976 Mar-Apr

Review 7.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

8.  The effect of BCG on experimental cutaneous leishmaniasis in mice.

Authors:  J Weintraub; F I Weinbaum
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

9.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  18 in total

1.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200.

Authors:  Mauro Cortez; Chau Huynh; Maria Cecilia Fernandes; Kathleen A Kennedy; Alan Aderem; Norma W Andrews
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

3.  Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.

Authors:  J El-On; G P Jacobs; E Witztum; C L Greenblatt
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

4.  Single gene control of resistance to cutaneous leishmaniasis in mice.

Authors:  L J DeTolla; P A Scott; J P Farrell
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 5.  Discovery and study of Leishmania turanica for the first time in China.

Authors:  L R Guan; Y Q Yang; J Q Qu; W X Shen
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

6.  Visceral Leishmania tropica infection of BALB/c mice: cellular analysis of in vitro unresponsiveness to sheep erythrocytes.

Authors:  C Leclerc; F Modabber; E Deriaud; J Djoko-Tamnou; L Chedid
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Studies on visceral Leishmania tropica infection in BALB/c mice. I. Clinical features and cellular changes.

Authors:  J Djoko-Tamnou; C Leclerc; F Modabber; L Chedid
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

8.  Immunopathology of experimental cutaneous leishmaniasis.

Authors:  Z A Andrade; S G Reed; S B Roters; M Sadigursky
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

9.  Visceral spreading depletion of thymus-dependent regions and amyloidosis in mice and hamsters infected intradermally with Leishmania isolated from Sudanese cutaneous leishmaniasis.

Authors:  B Veress; R E Abdalla; A M El Hassan
Journal:  Br J Exp Pathol       Date:  1983-10

10.  Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2.

Authors:  W Solbach; M Lohoff; H Streck; P Rohwer; M Röllinghoff
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.